HSA
CELG

Holt-Smith Advisors’s Celgene Corp CELG Stock Holding History

Holt-Smith Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$784K Buy
+13,406
New +$807K 1.11% 25

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Holt-Smith Advisors's CELG Position: Q2 2013 in Review

Holt-Smith Advisors opened a new position in Celgene Corp (CELG) in Q2 2013: 13,406 shares worth $784K. The stake represents 1.11% of the portfolio and ranks #25 among its holdings.

866 funds tracked by Wall St. Rank hold CELG as of Q2 2013.

  • Holt-Smith Advisors held 13,406 shares of Celgene Corp worth $784K as of Q2 2013.
  • Celgene Corp was a new Holt-Smith Advisors position in Q2 2013.
  • Celgene Corp made up 1.11% of Holt-Smith Advisors's portfolio in Q2 2013, its #25 holding.
  • 866 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2013.

Based on Holt-Smith Advisors's 13F filing for Q2 2013, filed 1 Aug 2013.